Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Next-generation biopharmaceutical downstream process

De 2015-03-01 à 2019-02-28, projet en cours

Détails concernant le projet

Coût total:

EUR 10 569 662,50

Contribution de l'UE:

EUR 8 366 432,50

Coordonné à/au(x)/en:

Slovenia

Appel à propositions:

H2020-LEIT-BIO-2014-1See other projects for this call

Régime de financement:

IA - Innovation action

Objectif

Coordinateur

LEK FARMACEVTSKA DRUZBA DD
Slovenia

Contribution de l'UE: EUR 2 631 737,50


VEROVSKOVA ULICA 57
1526 LJUBLJANA
Slovenia
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Participants

MILLIPORE SAS
France

Contribution de l'UE: EUR 1 764 962,50


39 Route Industrielle de la Hardt
67120 Molsheim
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITAET FUER BODENKULTUR WIEN
Austria

Contribution de l'UE: EUR 1 068 562,50


GREGOR MENDEL STRASSE 33
1180 WIEN
Austria
Activity type: Higher or Secondary Education Establishments
SANDOZ GMBH
Austria

Contribution de l'UE: EUR 376 512,50


Biochemiestraße 10
6250 Kundl
Austria
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
KARLSRUHER INSTITUT FUER TECHNOLOGIE
Germany

Contribution de l'UE: EUR 1 496 625


KAISERSTRASSE 12
76131 KARLSRUHE
Germany
Activity type: Higher or Secondary Education Establishments
KEMIJSKI INSTITUT
Slovenia

Contribution de l'UE: EUR 660 375


HAJDRIHOVA 19
1000 LJUBLJANA
Slovenia
Activity type: Research Organisations
NATIONAL SYSTEMS SRL
Italy

Contribution de l'UE: EUR 367 657,50


VIA GOITO 60
21019 SOMMA LOMBARDO VA
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Numéro d'enregistrement: 193337 / Dernière mise à jour le: 2016-09-21